Austar Lifesciences Limited (HKG:6118)

Austar Lifesciences Revenue

Austar Lifesciences had revenue of 661.91M CNY in the half year ending June 30, 2025, a decrease of -28.01%. This brings the company's revenue in the last twelve months to 1.46B, down -5.42% year-over-year. In the year 2024, Austar Lifesciences had annual revenue of 1.50B, down -14.93%.

• Revenue (ttm): 1.46B CNY
• Revenue Growth: -5.42%
• P/S Ratio: 0.29
• Revenue / Employee: 1.01M CNY
• Employees: 1,445
• Market Cap: 461.32M HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.50B	-263.33M	-14.93%
Dec 31, 2023	1.76B	-393.14M	-18.23%
Dec 31, 2022	2.16B	141.84M	7.04%
Dec 31, 2021	2.02B	719.05M	55.48%
Dec 31, 2020	1.30B	246.96M	23.54%